Search Results - Ana C. Thomaz
- Showing 1 - 3 results of 3
-
1
-
2
The cannabinoid CB2 receptor agonist LY2828360 synergizes with morphine to suppress neuropathic nociception and attenuates morphine reward and physical dependence by Vishakh Iyer, Richard A. Slivicki, Ana C. Thomaz, Jonathon D. Crystal, Ken Mackie, Andrea G. Hohmann
Published 2020Artigo -
3
Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal by Ailing Li, Xiaoyan Lin, Amey Dhopeshwarkar, Ana C. Thomaz, Lawrence M. Carey, Yingpeng Liu, Spyros P. Nikas, Alexandros Makriyannis, Ken Mackie, Andrea G. Hohmann
Published 2018Artigo
Search Tools:
Related Subjects
Medicine
Morphine
Opioid
Pharmacology
Receptor
(+)-Naloxone
Agonist
Allodynia
Cannabinoid
Cannabinoid receptor
Cannabinoid receptor type 2
Hyperalgesia
Internal medicine
Neuropathic pain
Nociception
Analgesic
Biochemistry
Bioinformatics
Biology
Chemistry
Conditioned place preference
Intestinal permeability
Microbiome
Opioid antagonist
Physical dependence